EFFECT OF DIETARY IRON ON MOTOR BEHAVIOR AND NEURONAL DEATH IN AN EXPERIMENTAL MODEL OF PARKINSONISM





C.W. Levenson*, W. Duan, R.G. Cutler, M.P. Mattson

Laboratory of Neurosciences, National Institutes on Aging, Gerontology Research Center, 5600 Nathan Shock Drive, Baltimore, MD 21224.



Because of the role of iron in oxidative processes, it has been speculated that high dietary iron may make neurons more vulnerable to damage and exacerbate neurodegenerative disorders associated with aging. This hypothesis is supported by the fact that high iron levels have been implicated in the development of Parkinson's disease (PD). Thus, this work was designed to test the impact of three levels of dietary iron on motor behavior and the development of an experimental model of PD. Two-month-old male C57BL/6 mice were fed diets containing low (4 ppm), normal (48 ppm) or high (400 ppm) iron for 6 weeks prior to the administration of MPTP, a mitochondrial toxin that causes the death of nigro-striatal dopaminergic neurons and induces PD-like symptoms. As expected, in mice fed the normal iron diet, MPTP impaired motor behavior as determined by the rotarod test (p<0.05). The low iron diet appeared to provide protection against the effects of MPTP on motor behavior, as the number of falls was not different from controls. Six weeks of iron supplementation significantly impaired motor behavior (p<0.001), and the combination of high dietary iron and MPTP treatment proved to be lethal. To understand the mechanisms that may be responsible for iron-induced neuronal death, primary cultures of rat hippocampal neurons were treated with increasing levels of iron. Iron treatment resulted in a dose-dependent decrease in neuronal survival that had the morphological characteristics of apoptosis, and was accompanied by increases in the generation of mitochondrial reactive oxygen species (ROS), and expression of the chaperone protein Hsp 70 and the pro-apoptotic tumor suppressor protein p53. Furthermore, cholesterol loading of cells prior to iron treatment significantly increased ROS production and decreased cell survival suggesting that iron, cholesterol, and its oxidative products may act synergistically to impair neuronal survival. In conclusion, these data suggest that dietary iron may play a role in the vulnerability of neurons to insults associated with PD and other neurodegenerative disorders.




Key words: iron, parkinson's disease, p53







Problems or questions regarding this site should be directed to webmaster@americanaging.org